<![CDATA[Background: Generalised Anxiety Disorder (GAD) is a chronic mental health condition characterised by persistent and excessive worry that lasts for at least six months and interferes with daily functioning. The disorder affects adolescents and adults worldwide and is frequently accompanied by psychological and somatic symptoms such as restlessness, fatigue, sleep disturbance, irritability, and impaired concentration. Because these symptoms often appear in primary health settings, accurate diagnosis remains challenging. Objective: This article reviews the aetiology, clinical characteristics, and current treatment options for GAD, highlighting emerging therapeutic approaches. Method: The study employs a narrative literature review of recent psychological and psychiatric publications on diagnostic criteria, epidemiology, pharmacological management, and cognitive-behavioural interventions. Results: Findings indicate that GAD presents with diverse symptom trajectories across the lifespan and disproportionately affects certain populations, including women and older adults. Evidence also shows that combined pharmacotherapy and cognitive behavioural therapy remains the most effective treatment, while mindfulness-based and integrative therapies demonstrate promising complementary outcomes. Conclusion: Generalized Anxiety Disorder (GAD) is most effectively managed through an integrated treatment model combining Cognitive Behavioral Therapy (CBT), pharmacotherapy, and complementary approaches such as mindfulness; however, optimizing clinical outcomes requires future interventions to be more personalized, culturally sensitive, and focused on early prevention. Originality/Value: This study broadens theoretical and clinical perspectives in Clinical Psychology and Psychiatry by integrating conventional pharmacological approaches with psychotherapeutic interventions (CBT and mindfulnessbased therapies) to explain the multidimensional treatment dynamics of Generalized Anxiety Disorder (GAD) across the lifespan, an area often discussed in frag-mented silos. The comprehensive framework presented serves as a strategic reference for primary care physicians, clinicians, and researchers in designing individualized multimodal treatment protocols and developing future empirical research on integrative therapeutic outcomes.]]>
